Be
Stock
Your Best Stock
Home
Stock Quotes
Markets
Stock Analysis
Broker Reviews
About
Stocks
›
Biotechnology
›
VRTX
Vertex Pharmaceuticals
VRTX
US equity
Market cap rank #116
Biotechnology
Gene Editing
$521.79
+$5.45
(+1.05%)
Market open · Sep 24, 2:00 pm ET
After hours $517.00
+0.13%
Open
$515.56
Prev close
$516.34
Day range
$515.30 – $528.89
Volume
376.3K
Market cap
$132.25B
P/E (TTM)
30.4
Dividend yield
–
Overview
Technicals
Financials
Earnings
Valuation
Analysts
Dividends
Options
Ownership
News
Profile
News On Crinetics Pharmaceuticals Inc. (CRNX) Now Under VRTX
Dow Jones · 2 Sep 2026
Morgan Stanley Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $665
Market news · 2 Sep 2026
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)
TipRanks · 2 Sep 2026
Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $585
Market news · 2 Sep 2026
Scotiabank Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $558
Market news · 16 Sep 2026
Morgan Stanley Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $665
Market news · 15 Sep 2026
J.P. Morgan Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $560
Market news · 11 Sep 2026
Vertex Pharmaceuticals Names Jonathan Poole Chief Financial Officer, Effective Jan. 1 VRTX
Dow Jones · 1 Sep 2026
UBS Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $585
Market news · 20 Aug 2026
BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $600
Market news · 18 Aug 2026
RBC Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $570
Market news · 13 Aug 2026
A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $558 to $633
Market news · 12 Aug 2026
Scroll to Top